Imatinib Mesylate contains not less than 98.0% and not more than 102.0% of C30H35N7SO4, calculated on the anhydrous basis.

共有 1 個藥物證書使用此成份

甲磺酸伊馬替尼
Imatinib Mesylate

• 申請商: 宇直泰貿易股份有限公司
• 適應症: 白血病用藥
• 發證日期: 2021-03-15